ArticleResearch and practice in thrombosis and haemostasis2025
Adenovirus vectors can infect mouse megakaryocytes - implications for vaccine-induced thrombosis/thrombocytopenia.
Article in Research and practice in thrombosis and haemostasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adenoviruses, adenoviral vector vaccines, and gene delivery systems have been implicated in thrombosis/thrombocytopenia syndrome. The underlying cause remains unknown. We have previously hypothesized that infection of megakaryocytes (MKs), the progenitor cells of platelets, plays a central role in adenovirus- or adenoviral vector-induced thrombosis/thrombocytopenia. Further, recent work has highlighted that the MK population comprises multiple subsets, including cells with immune function, and we propose that this MK subset is involved in adenoviral infection and the subsequent response. Objectives: To determine whether MKs are permissive to infection by recombinant adenovirus encoding the SARS-CoV-2 spike protein, and whether infection is associated with phenotypic changes. Methods: In this work, we generated adenovirus vectors based on the adenovirus 5 strain, with a green fluorescence protein reporter gene and encoding or not the SARS-CoV-2 Spike protein. Megakaryoblastic cell lines and MKs derived from mouse bone marrow and differentiated with thrombopoietin were exposed to adenoviral vectors, and infection was analyzed using flow cytometry and fluorescence microscopy. Results: The primary finding of this study is that MKs were permissive to infection by recombinant adenoviruses carrying the Spike gene of ß-SARS-CoV-2, with higher rates of infection in mature MKs. Furthermore, the effect of adenoviral infection on the cell surface proteins CD41, CD42, and CXCR4 was investigated. Cell cultures stimulated with bacterial lipopolysaccharide, with and without concurrent adenoviral infection, demonstrated that lipopolysaccharide stimulation and adenoviral infection at moderate multiplicity of infection drove increased surface expression of the α chemokine receptor CXCR4, whereas adenoviral infection at a high multiplicity of infection reduced CXCR4 expression. Conclusion: We found that adenoviral infection was higher in higher-ploidy CD41
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.